🏠 Home
Health
🏥
Health
16 channels · 4,520 articles
Articles
More REM sleep linked to lower risk of 83 diseases
A large study tracking more than 95,000 people suggests that how you sleep may be linked to your risk of developing dozens of diseases. People who spent more time in REM sleep had lower risks of 83 conditions, including dementia, heart failure, and Parkinson’s disease, while more deep sleep was associated with lower risks of conditions such as type 2 diabetes and major depression.
0
2
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies. A new study found that nearly 1 in 6 young patients developed a diagnosed deficiency within a year of starting treatment, with vitamin D deficiency affecting about 12%.
0
2
White House plan to increase control of NIH grants appears ‘dead’
A planned executive order that would have greatly enhanced White House influence over grants at the National Institutes of Health is “looking dead,” according to one person familiar with the decision and Sen. Susan Collins (R-Maine).
On Tuesday, Collins, the chair of the appropriations committee, sent a letter to Office of Management and Budget Director Russell Vought and NIH Director Jay Bhattacharya, decrying the White House plan to establish a commission of political appoin
0
2
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
(MedPage Today) -- While taking oral menopausal hormone therapy, women faced increased thrombotic risks that varied by the method of use, dosage, and duration of treatment, a nationwide study from Denmark showed.
Venous thromboembolic risk remained...
0
2
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
WASHINGTON — In her opening statement for Thursday’s hearing before a key Senate committee, President Trump’s pick to lead the Food and Drug Administration, Heidi Overton, plans to emphasize the need for speed and efficiency at the FDA to compete with China’s accelerating biotechnology industry. 
“President Trump’s direction for me in this role, should I be confirmed, is to ‘go fast.’” Overton says in the statement, an advanc
0
3
Gifts from Friends provides thoughtful way to celebrate
Share a sweet holiday gift that gives back! Along with festive cards, Gifts from Friends offers Christie Cookie and Bellafina chocolate tins featuring artwork created by patients at Monroe Carell Jr. Children’s Hospital at Vanderbilt. These products are a thoughtful way to thank colleagues, recognize partners or celebrate the season with friends and family. Each tin showcases the creativity and spirit of our patients, and proceeds support programs that benefit children and families through Frien
0
2
Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4
The post Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4 appeared first on Vanderbilt Health News.
0
2
Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27
The post Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27 appeared first on Vanderbilt Health News.
0
2
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer, concluding that the benefits of the test outweighed its risks.
The panel voted 10 to 0 that it believed there is “reasonable assurance” the test is safe. The panel voted 6 to 4 that there was reasonable assurance the test is effective. And it voted 7 to 2 with one abstention that it believed “the benefits of G
0
2
Congo Is Running Short of Health Workers as Ebola Remains Out of Control, WHO Says
(MedPage Today) -- Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebola outbreak, particularly in the eastern province of North Kivu where cases have surged 73% over 3 weeks, the World Health Organization...
0
1
Christmas Village to be held Nov. 13-15 at the Nashville Fairgrounds
Since its debut in 1961, Christmas Village has raised more than $15.5 million, positively impacting thousands of lives. Proceeds from this charitable event benefit The Vanderbilt Bill Wilkerson Center and its Pi Beta Phi Rehabilitation Institute, supporting patients with neurological conditions, spinal cord injuries, and stroke recovery.
Christmas Village will feature more than 250 merchants. Available items include home decor, handcrafted pottery, clothing for children and adults, jewelry a
0
2
Medical Aid in Dying Keeps Expanding to More States
(MedPage Today) -- The practice of allowing a doctor to help terminally ill patients end their lives with medication has been legalized in recent years in several countries across the world.
In the U.S., New York and Illinois recently became the...
0
2
New Autism Committee Chair Founded a Leucovorin Telehealth Company
(MedPage Today) -- John Gaitanis, MD, who was recently appointed the new chair of the federal Interagency Autism Coordinating Committee (IACC), co-founded a company that provides leucovorin to families of children with autism.
Meadow Biosciences...
0
2
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X accelerator for behavioral health and addiction startups
Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health through the Brock Family Center for Applied Innovation to power its 2026 HealthTech|X cohort. The dual-region program will support startups building technology for behavioral health and addiction, two of the fastest-growing and most urgent categories in the industry.
Through the partnership, founders selected for the cohort will have direct access to Vanderbilt researchers, c
0
2
Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer
(MedPage Today) -- Older age should not discourage healthy women with a genetic risk for ovarian cancer from considering risk-reducing bilateral salpingo-oophorectomy (BSO), investigators in a study of BRCA carriers concluded.
A 30-year-old BRCA1...
0
1
FDA Warns Pharmacy About Illegal GLP-1 Compounding
(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions.
Following a facility...
0
2
Nearly 1 in 3 People With Lyme Disease Bacteria Carry Other Tick-Borne Pathogens
(MedPage Today) -- Nearly one-third of people who tested positive for the bacteria that cause Lyme disease also tested positive for other tick-borne pathogens, according to a retrospective cohort study.
Among 193,260 people tested for tick-borne...
0
1
A Dementia Vaccine? Most Americans Say Yes
(MedPage Today) -- Most Americans 50 and older said they would be interested in receiving a vaccine that could reduce their risk of dementia if they were at high risk, survey data showed.
Nearly three in four survey respondents (72.1%) said they...
0
1
Vanderbilt Health leaders advance a collaborative agenda to engineer the elimination of targeted diseases
Vanderbilt Health leaders André L. Churchwell, MD, Professor of Medicine in the Division of Cardiovascular Medicine, and Reed A. Omary, MD, MS, Professor of Radiology and Biomedical Engineering, are helping advance a national effort to move care upstream: from treating disease after it emerges to preventing, interrupting and ultimately eliminating targeted diseases.
André L. Churchwell, MD, with MD Anderson’s Katy Rezvani, MD, PhD. Churchwell is on the board of the International Society
0
1
Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged.
Many mental health and suicide risk indicators among youth...
0
2
More REM sleep linked to lower risk of 83 diseases
A large study tracking more than 95,000 people suggests that how you sleep may be linked to your risk of developing doze
0
2
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or ty
0
2
White House plan to increase control of NIH grants appears ‘dead’
A planned executive order that would have greatly enhanced White House influence over grants at the National Institutes
0
2
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
(MedPage Today) -- While taking oral menopausal hormone therapy, women faced increased thrombotic risks that varied by t
0
2
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
WASHINGTON — In her opening statement for Thursday’s hearing before a key Senate committee, President Trum
0
3
Gifts from Friends provides thoughtful way to celebrate
Share a sweet holiday gift that gives back! Along with festive cards, Gifts from Friends offers Christie Cookie and Bell
0
2
Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4
The post Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4 appeared first o
0
2
Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27
The post Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27 appeared first on
0
2
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm G
0
2
Congo Is Running Short of Health Workers as Ebola Remains Out of Control, WHO Says
(MedPage Today) -- Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebo
0
1
Christmas Village to be held Nov. 13-15 at the Nashville Fairgrounds
Since its debut in 1961, Christmas Village has raised more than $15.5 million, positively impacting thousands of lives.
0
2
Medical Aid in Dying Keeps Expanding to More States
(MedPage Today) -- The practice of allowing a doctor to help terminally ill patients end their lives with medication has
0
2
New Autism Committee Chair Founded a Leucovorin Telehealth Company
(MedPage Today) -- John Gaitanis, MD, who was recently appointed the new chair of the federal Interagency Autism Coordin
0
2
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X accelerator for behavioral health and addiction startups
Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health t
0
2
Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer
(MedPage Today) -- Older age should not discourage healthy women with a genetic risk for ovarian cancer from considering
0
1
FDA Warns Pharmacy About Illegal GLP-1 Compounding
(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded
0
2
Nearly 1 in 3 People With Lyme Disease Bacteria Carry Other Tick-Borne Pathogens
(MedPage Today) -- Nearly one-third of people who tested positive for the bacteria that cause Lyme disease also tested p
0
1
A Dementia Vaccine? Most Americans Say Yes
(MedPage Today) -- Most Americans 50 and older said they would be interested in receiving a vaccine that could reduce th
0
1
More REM sleep linked to lower risk of 83 diseases
A large study tracking more than 95,000 people suggests that how you sleep may be linked to your risk of developing dozens of dise…
💬 0
👁 2
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Health & Medicine News -- ScienceDaily · 1d ago
💬 0
👁 2
White House plan to increase control of NIH grants appears ‘dead’
STAT · 1d ago
💬 0
👁 2
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
MedPageToday.com - medical news for physicians · 1d ago
💬 0
👁 2

STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
STAT · 1d ago
Gifts from Friends provides thoughtful way to celebrate
Vanderbilt Health News · 1d ago
Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4
Vanderbilt Health News · 1d ago
Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27
Vanderbilt Health News · 1d ago
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to sc…
💬 0
👁 2
Congo Is Running Short of Health Workers as Ebola Remains Out of Control, WHO Says
MedPageToday.com - medical news for physicians · 1d ago
💬 0
👁 1
Christmas Village to be held Nov. 13-15 at the Nashville Fairgrounds
Vanderbilt Health News · 1d ago
💬 0
👁 2
Medical Aid in Dying Keeps Expanding to More States
MedPageToday.com - medical news for physicians · 1d ago
💬 0
👁 2

New Autism Committee Chair Founded a Leucovorin Telehealth Company
MedPageToday.com - medical news for physicians · 1d ago
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X accelerator for behavioral health and addiction startups
Vanderbilt Health News · 1d ago

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer
MedPageToday.com - medical news for physicians · 1d ago

FDA Warns Pharmacy About Illegal GLP-1 Compounding
MedPageToday.com - medical news for physicians · 1d ago
Nearly 1 in 3 People With Lyme Disease Bacteria Carry Other Tick-Borne Pathogens
(MedPage Today) -- Nearly one-third of people who tested positive for the bacteria that cause Lyme disease also tested positive fo…
💬 0
👁 1
A Dementia Vaccine? Most Americans Say Yes
MedPageToday.com - medical news for physicians · 1d ago
💬 0
👁 1
Vanderbilt Health leaders advance a collaborative agenda to engineer the elimination of targeted diseases
Vanderbilt Health News · 1d ago
💬 0
👁 1
Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
MedPageToday.com - medical news for physicians · 2d ago
💬 0
👁 2
More REM sleep linked to lower risk of 83 diseases
A large study tracking more than 95,000 people suggests that how you sleep may be linked to your risk of developing dozens of diseases. People who spent more time in REM sleep had lower risks of 83 conditions, including dementia, heart failure, and Parkinson’s disease, while more deep sleep was associated with lower risks of conditions such as type 2 diabetes and major depression.
0
2 👁
GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies. A new study found that nearly 1 in 6 young patients developed a diagnosed deficiency within a year of starting treatment, with vitamin D deficiency affecting about 12%.
0
2 👁
White House plan to increase control of NIH grants appears ‘dead’
A planned executive order that would have greatly enhanced White House influence over grants at the National Institutes of Health is “looking dead,” according to one person familiar with the decision and Sen. Susan Collins (R-Maine).
On Tuesday, Collins, the chair of the appropriations committee, sent a letter to Office of Management and Budget Director Russell Vought and NIH Director Jay Bhattacharya, decrying the White House plan to establish a commission of political appoin
0
2 👁
Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration
(MedPage Today) -- While taking oral menopausal hormone therapy, women faced increased thrombotic risks that varied by the method of use, dosage, and duration of treatment, a nationwide study from Denmark showed.
Venous thromboembolic risk remained...
0
2 👁
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
WASHINGTON — In her opening statement for Thursday’s hearing before a key Senate committee, President Trump’s pick to lead the Food and Drug Administration, Heidi Overton, plans to emphasize the need for speed and efficiency at the FDA to compete with China’s accelerating biotechnology industry. 
“President Trump’s direction for me in this role, should I be confirmed, is to ‘go fast.’” Overton says in the statement, an advanc
0
3 👁
Gifts from Friends provides thoughtful way to celebrate
Share a sweet holiday gift that gives back! Along with festive cards, Gifts from Friends offers Christie Cookie and Bellafina chocolate tins featuring artwork created by patients at Monroe Carell Jr. Children’s Hospital at Vanderbilt. These products are a thoughtful way to thank colleagues, recognize partners or celebrate the season with friends and family. Each tin showcases the creativity and spirit of our patients, and proceeds support programs that benefit children and families through Frien
0
2 👁
Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4
The post Educator Development Program workshop, ‘Learner Assessment in the Clinical Setting,’ is Nov. 4 appeared first on Vanderbilt Health News.
0
2 👁
Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27
The post Educator Development Program workshop, ‘Models of Program Evaluation,’ is Oct. 27 appeared first on Vanderbilt Health News.
0
2 👁
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer, concluding that the benefits of the test outweighed its risks.
The panel voted 10 to 0 that it believed there is “reasonable assurance” the test is safe. The panel voted 6 to 4 that there was reasonable assurance the test is effective. And it voted 7 to 2 with one abstention that it believed “the benefits of G
0
2 👁
Congo Is Running Short of Health Workers as Ebola Remains Out of Control, WHO Says
(MedPage Today) -- Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebola outbreak, particularly in the eastern province of North Kivu where cases have surged 73% over 3 weeks, the World Health Organization...
0
1 👁
Christmas Village to be held Nov. 13-15 at the Nashville Fairgrounds
Since its debut in 1961, Christmas Village has raised more than $15.5 million, positively impacting thousands of lives. Proceeds from this charitable event benefit The Vanderbilt Bill Wilkerson Center and its Pi Beta Phi Rehabilitation Institute, supporting patients with neurological conditions, spinal cord injuries, and stroke recovery.
Christmas Village will feature more than 250 merchants. Available items include home decor, handcrafted pottery, clothing for children and adults, jewelry a
0
2 👁
Medical Aid in Dying Keeps Expanding to More States
(MedPage Today) -- The practice of allowing a doctor to help terminally ill patients end their lives with medication has been legalized in recent years in several countries across the world.
In the U.S., New York and Illinois recently became the...
0
2 👁
New Autism Committee Chair Founded a Leucovorin Telehealth Company
(MedPage Today) -- John Gaitanis, MD, who was recently appointed the new chair of the federal Interagency Autism Coordinating Committee (IACC), co-founded a company that provides leucovorin to families of children with autism.
Meadow Biosciences...
0
2 👁
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X accelerator for behavioral health and addiction startups
Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health through the Brock Family Center for Applied Innovation to power its 2026 HealthTech|X cohort. The dual-region program will support startups building technology for behavioral health and addiction, two of the fastest-growing and most urgent categories in the industry.
Through the partnership, founders selected for the cohort will have direct access to Vanderbilt researchers, c
0
2 👁
Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer
(MedPage Today) -- Older age should not discourage healthy women with a genetic risk for ovarian cancer from considering risk-reducing bilateral salpingo-oophorectomy (BSO), investigators in a study of BRCA carriers concluded.
A 30-year-old BRCA1...
0
1 👁
FDA Warns Pharmacy About Illegal GLP-1 Compounding
(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions.
Following a facility...
0
2 👁
Nearly 1 in 3 People With Lyme Disease Bacteria Carry Other Tick-Borne Pathogens
(MedPage Today) -- Nearly one-third of people who tested positive for the bacteria that cause Lyme disease also tested positive for other tick-borne pathogens, according to a retrospective cohort study.
Among 193,260 people tested for tick-borne...
0
1 👁
A Dementia Vaccine? Most Americans Say Yes
(MedPage Today) -- Most Americans 50 and older said they would be interested in receiving a vaccine that could reduce their risk of dementia if they were at high risk, survey data showed.
Nearly three in four survey respondents (72.1%) said they...
0
1 👁
Vanderbilt Health leaders advance a collaborative agenda to engineer the elimination of targeted diseases
Vanderbilt Health leaders André L. Churchwell, MD, Professor of Medicine in the Division of Cardiovascular Medicine, and Reed A. Omary, MD, MS, Professor of Radiology and Biomedical Engineering, are helping advance a national effort to move care upstream: from treating disease after it emerges to preventing, interrupting and ultimately eliminating targeted diseases.
André L. Churchwell, MD, with MD Anderson’s Katy Rezvani, MD, PhD. Churchwell is on the board of the International Society
0
1 👁
Safety Concerns Halt Depression Trials; Gen Z and Alcohol; Prescribing Benzos
(MedPage Today) -- Xenon Pharmaceuticals said it paused enrollment in its major depressive disorder and bipolar depression trials after unexpected neuropsychiatric adverse events emerged.
Many mental health and suicide risk indicators among youth...
0
2 👁